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Neonatal transfusions provide challenges at several steps in the
process. Neonates are often transfused with relatively small volumes
at slow flow rates from syringes,whereas at other times they require
relatively massive transfusions or exchange transfusions. To facilitate
these specialized transfusions, blood banks often modify their
procedures to provide small volumes of blood components that are
sometimes dispensed in syringes or to reconstitute whole blood for
exchange transfusions. Hospitals must implement policies and
procedures to ensure that the blood components are transfused
safely when using these specialized techniques for infants.
Nevertheless, some issues remain in many hospitals, such as the
difficulty in safely warming blood components for neonatal
transfusions and the difficulties in using approved labels for small
containers that are sometimes prepared at the bedside.
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Neonatal Transfusion Volumes
The large variation in volumes transfused to
neonates impacts the processes for preparing blood
components in the blood bank and for transfusing the
patient at the bedside. Neonates can receive very small
simple transfusions or larger transfusions,some of which
are considered massive.
Large transfusions including massive transfusions
can occur in one of several settings. Exchange trans-
fusions, which are most frequently performed for
neonatal hyperbilirubinemia,usually consist of exchang-
ing two blood volumes with reconstituted whole blood.
Some surgical procedures result in substantial hemor-
rhage, necessitating large and sometimes massive
transfusions. Other scenarios in which neonates
commonly receive massive transfusions include those
when the patient is placed on an extracorporeal circuit
such as a cardiopulmonary bypass circuit or an
extracorporeal membrane oxygenation circuit.
An entire massive transfusion for a neonate may be
obtained from 1 unit because the volume in 1 RBC unit
may be more than the blood volume of the neonate.
Very small premature infants have blood volumes of up
to 100 mL/kg, which means, for example that a 1500-g
premature infant has a blood volume of up to 150 mL,
which is less than the volume of 1 RBC unit.
Although “massive transfusions” for an infant are
relatively small and may be less than 1 unit of RBCs,
standard simple transfusions can be extremely small.
Indeed, an entire simple transfusion usually consists of
less than 50 mL. A standard transfusion of RBCs or
plasma or platelets usually consists of 5 to 15 mL/kg. For
example, in the 1500-g premature infant, an entire
simple transfusion would be approximately 10 mL.
Venous Access
Transfusions can be performed via a large-bore
central catheter, a small-bore central catheter, or a
peripheral venous catheter. A large-bore central catheter
is used for extracorporeal circuits in which the
“transfusion” is an integral part of the circuit. Other
neonates sometimes have small-bore central catheters.
However,some people prefer to reserve these catheters
for nutrient solutions or drugs because of concerns
about clogging a small-bore central catheter with a
blood transfusion.1 Hence,small peripheral needles are
often used for transfusions.
Rapid transfusion through narrow peripheral
needles can cause small amounts of hemolysis in some
situations.2,3 Although the resulting hemolysis may be
measurable and even cause hemoglobinuria in rare
circumstances, it is rarely if ever clinically significant.
The most potentially dangerous effect of hemolysis at
the needle would be the effect of transfusing free
potassium. However,more potassium is liberated from
RBCs during storage than is released via hemolysis at the
needle, and it would be extremely unlikely that enough
potassium would be transfused through a small-bore
needle to induce dangerous hyperkalemia.2
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Blood Warmers
Unfortunately, no blood warmers available in the
United States are specifically designed for neonatal
transfusions. There are some disadvantages associated
with using blood warmers designed for adult
transfusions for neonatal transfusions. One disadvantage
is that the volume of fluid required for the blood
warmer is often larger than the volume to be transfused,
which means that some of the blood component will
often be wasted. Another disadvantage associated with
some blood warmers is that because the flow rate for
neonatal transfusions is relatively slow, the blood may
reequilibrate to ambient room temperature after passing
through the blood warmer but before entering the
patient’s circulation. However, most simple neonatal
transfusions do not need to be warmed.
Transfusion Techniques—Controlling Flow
Rate
Except for transfusions that are an integral part of a
circuit, most neonatal transfusions are administered
from a syringe. Although the syringe plunger may be
manually pressed, most simple transfusions are
administered using a syringe pump to control the
transfusion rate,which is usually approximately 5 to 15
mL/kg per hour.
Syringes
Unlike most transfusions, neonatal transfusions
usually require transfer of a blood component into a
syringe before the actual transfusion. This step often
occurs at the patient’s bedside,but some hospital blood
banks transfer blood components into syringes for select
neonatal transfusions.
When a relatively large volume of a unit
(approximately one half) might be transfused,the blood
bank often prepares the unit using procedures identical
to those used for most transfusions of larger patients;
blood is dispensed in a standard blood bag. The
transfusionist might then transfer aliquots of the unit
into a syringe at the patient’s bedside so that the
transfusion rate and volume can be controlled. The
transfusionist can connect the blood bag to a syringe
through a three-way stopcock, with the other port on
the stopcock connected to a catheter that enters the
patient’s circulation. Using this setup, the blood
component can be filtered while it is transferred from
the bag to the syringe using a blood administration set;
then the stopcock is readjusted, and the blood
component is then transfused from the syringe. One
risk associated with this approach is that RBCs could
hemolyze if forced through an improperly adjusted
stopcock, but this rarely causes clinically significant
problems.
Some blood banks transfer blood components into
syringes for clinical areas such as the neonatal intensive
care unit. The blood bank may simply transfer the blood
into a syringe using the same connection devices that
would be used by the clinical area. The disadvantage of
this approach is that the remainder of the blood
component will have a reduced shelf life because the
system has been opened and is susceptible to
contamination. AABB Standards limits the shelf life of
such a unit to 24 hours from the time the unit is entered.4
If the blood bank has a sterile docking device, it can
connect a blood administration set to the tubing that is
part of the blood unit. The blood bank then transfers a
portion of the blood component into a syringe,seals off
the tubing,and disconnects the blood administration set
from the blood bag. This allows the remainder of the
blood component to be stored and used at a later date.5
It is advisable to minimize the time that platelets are
stored in syringes,which,unlike platelet storage bags,are
made of gas-impermeable plastic. Platelets are meta-
bolically active, and platelets stored in syringes become
depleted of oxygen and use anaerobic metabolism.6,7
This results in the generation of lactic acid and decreases
the pH of the platelet component.6–8 This effect happens
more rapidly in conditions that favor greater metabolic
activity, including storage at 37°C and storage of volume-
reduced platelets.6,7 Although storage in syringes for up
to 6 hours results in platelets that are generally
acceptable by FDA standards and that appear acceptable
after passage through a syringe, it is advisable to avoid
storage at 37°C and to minimize storage times and
storage of volume-reduced platelets.7,8
Satellite Bags
Some hospital transfusion services dispense blood
components in satellite bags instead of, or in addition
to, syringes. Syringe aliquoting is most useful when the
transfusion service has a sterile connection device to
attach the blood administration set to a blood
component unit. Without a sterile connection device,
the blood administration set must be spiked into the
blood component unit, which opens the system,
increasing the risk of contamination and limiting the
shelf life of the remaining unit to no more than an
additional 24 hours byAABB Standards.4
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A variety of satellite bag systems are available, all of
which are designed to provide aliquots of the original
blood component units in smaller bags. These systems,
such as some“pediatric packs”provided by some blood
centers,contain several (usually six) satellite blood bags
containing aliquots of the original RBC unit. When they
are prepared by a blood center, sterility of the system is
maintained and the RBC units have the same outdate as
a nonaliquoted RBC unit. Similar systems, such as the
Pedi-Pak (Genesis BPS, Hackensack, NJ) are available to
hospital transfusion services. With these systems,staff in
the transfusion service can aliquot a unit into smaller
bags,either with or without a sterile connection device.
Without the sterile connection device, the shelf life of
the unit is decreased,but this may still be useful because
it allows 1 unit to be used for several babies in 1 day or
several aliquots of 1 unit to be used for one baby who
requires multiple transfusions during 1 day.
Satellite bag systems are also available for plasma.
Most commonly, a unit of plasma is divided into 4 to 6
smaller subunits before freezing, and blood suppliers
can often provide this. The transfusion service then
thaws a small dose of plasma when needed. The unit
can be thawed in the same warmers used for standard
units, but the thawing times differ and each laboratory
should determine the thawing times for the different
types of frozen plasma units that are used. When using
a standard plasma warmer device, the thawing time
depends on the dimensions of the unit and is especially
dependent on the unit’s thickness. Hence,smaller units
sometimes take more time to thaw than larger units.
Alternatively, a plasma unit can be aliquoted into
satellite bags after thawing, using a sterile connection
device. This might be useful if no small frozen plasma
units are available and several pediatric doses are
needed. Additionally, if one infant is expected to need
several plasma doses,donor exposure can be limited by
transfusing with aliquots from the same thawed unit.
Filtering
All blood components should be filtered near the
time of transfusion, as required by accrediting
organizations such as the AABB.9 This filtering step,
which is in addition to optional filtering to reduce
leukocyte concentration, is designed to remove any
aggregates that may develop during storage of blood
components. Although this filtering is generally
performed when the blood component is transfused,the
most common exception occurs with neonatal
transfusions, in which the blood component is often
filtered when it is transferred into a syringe. This
exception is allowed because it is extremely difficult to
appropriately prime a catheter and blood filter and then
precisely control the transfusion volume flow rate when
the syringe is connected to a filter during the transfusion.
Because filtering is often most conveniently performed
when the blood component is transferred into a syringe,
the blood bank may filter the blood component.
Some facilities use blood administration sets
especially designed for neonatal transfusions. These sets
are designed to minimize the priming volume and blood
losses that occur in standard blood administration sets.
Indeed, it is not unusual for up to 40 mL to be lost in the
standard blood administration set. Neonatal blood
administration sets have smaller filters and narrower
catheters that are often shorter to minimize these
volumes. Additionally, manufacturers such as Charter
Medical, Ltd.,Winston-Salem, North Carolina, sell sets
with various configurations, such as sets with a syringe
or syringes preattached to facilitate transfer into syringes
within a sterile closed system.5 With these systems,
volume losses can be minimized to 1 to 3 mL for each
aliquot that is prepared from a unit, and some blood
banks have reported preparing more than 20 aliquots
from 1 unit of a blood component.
Irradiation
Cellular blood components, including RBCs, whole
blood, and platelets, may be irradiated to prevent
transfusion-associated GVHD. The shelf life and function
of platelets is not affected by irradiation.10–13 However,
RBC units are affected by irradiation, which should be
considered in blood bank policies and procedures.
Potassium is released from RBCs during storage,and
this process is substantially hastened by irradiation.14 To
minimize exposure to extracellular potassium, the unit
should be irradiated as close to the time of transfusion
as possible if the unit will be used for a large and rapid
transfusion.15,16 This is recommended because case
reports suggest that neonates are particularly
susceptible to transfusion-associated hyperkalemia,
which occurs,although rarely,when they are transfused
with RBC units or whole blood that contains elevated
potassium concentrations in the supernatant.17 If it is
not possible to provide freshly irradiated units, either
because of a lack of inventory of appropriate units or
because the hospital transfusion service lacks an
irradiator, then the units used for large transfusions can
be washed to remove most of the extracellular
potassium.
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Washing and Concentrating Blood
Components
Although the methods used to wash blood
components for neonates are the same as those used to
wash blood components for older patients, a few
possible indications for washing are more common in
neonates. Case reports suggest that transfusion of
plasma-containing components increases hemolysis
owing to T-cell activation in neonates, and hence
washing may be indicated for these patients.18 Although
transfused potassium is not problematic for standard
simple transfusions, it may be problematic for large
transfusions for very young patients, and RBC units are
sometimes washed to reduce extracellular potassium.
Although this is effective for the first 2 to 3 hours after
washing, potassium can rapidly rise after washing,
and 18 hours after washing irradiated RBC units,
the extracellular potassium concentration can exceed
15 mEq/L.19
Although there is little evidence that concentrated
RBCs or platelets are beneficial for neonatal transfusions,
some transfusion services provide concentrated RBCs
and platelets. A dose of RBCs concentrated to a hemato-
crit of approximately 68% can be obtained by removing
the aliquot from an RBC unit that has been hanging
upside down in the refrigerator for 72 hours.20
Alternatively,some have developed methods to concen-
trate RBCs to more than 80 percent by centrifuging the
unit at 4000 × g for 4 minutes and transferring a portion
of the concentrated RBCs to a satellite bag.21,22
Platelets can be concentrated by centrifugation,
removal of some supernatant, and resuspending the
remaining platelets.23 However, the additional
manipulation of platelets required to wash or volume-
reduce platelets causes platelet loss,can cause clumping,
and may induce some platelet dysfunction.
Exchange Transfusions
Special considerations apply to a neonatal exchange
transfusion,which involves a massive transfusion for an
infant. The methods used to prepare the blood
component and perform the exchange are designed to
minimize the risk involved with the procedure.
Two blood volumes are usually exchanged, with a
neonate’s blood volume ranging from 85 mL/kg for full
term infants to 100 mL/kg for very low birth weight
infants. Most frequently, the neonate’s blood is ex-
changed with reconstituted whole blood with a
hematocrit of 40 to 60% that is prepared from RBC units
and plasma.24,25 Often the first step in preparing
reconstituted whole blood is to remove the supernatant
from the RBC unit, especially if the RBC unit contains
an additive. Although this can be accomplished by
washing the unit in an automated blood washer, a
modified method in which normal saline solution is
added, the unit is centrifuged, and most of the
supernatant is removed removes sufficient amounts of
supernatant for this purpose. When the RBC unit is
ready for reconstitution, the hematocrit of the unit is
measured, and the amount of plasma needed to dilute
the RBC unit to the desired final hematocrit is
calculated.
The exchange transfusion is sometimes performed
through simultaneous withdrawal and transfusion
through two sites of vascular access.26,27 However, the
discontinuous method is more frequently used. With the
discontinuous method, a stopcock is used to alternate
transfusion and withdrawal of blood through one site.28
With the discontinuous method,usually no more than 5
mL/kg of blood is withdrawn and replaced during each
replacement cycle. With either method,a blood warmer
is usually recommended, and the unit should be kept
well mixed throughout the procedure.
Labels
Bags and syringes of blood used for transfusion need
to be labeled, and all FDA-licensed and registered
facilities and allAABB-accredited facilities will soon need
to be in full compliance with ISBT standards.29,30 These
regulations apply regardless of where the aliquot is
prepared. In most cases,the labels for aliquots will need
to be provided by the hospital transfusion service even
if the aliquot is prepared at the bedside. Because labels
need to be in compliance with specific size require-
ments, facilities are developing labels and techniques
that permit the labels to be used with syringes and
syringe pumps. For example, some labels may need to
be folded back to permit visualization of the blood
component in a syringe.
Summary
Two issues result in the use of special techniques
when preparing and transfusing blood components for
neonates. First, neonates can be especially susceptible
to some transfusion risks such as metabolic abnormal-
ities and fluid shifts. Hence, blood banks and clinical
areas avoid transfusing fluids containing nonphysiologic
electrolyte concentrations and using rapid transfusion
rates whenever possible. Second,standard supplies and
equipment are designed for transfusion of larger
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patients. In some cases, hospitals need to use
equipment that is not well designed for neonatal
transfusions, such as blood warmers. In other cases,
equipment and supplies for neonatal transfusions are
available, such as satellite bags, pediatric filters, syringe
pumps, and syringes. In these cases, hospitals must
consider the impact that these systems have on
workflow and the potency and purity of transfused
blood components.
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